Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2008
11/12/2008CN100431613C Two kinds of novel angiogenesis-inhibiting medicine and its uses in preventing and treating tumour
11/12/2008CN100431612C Hepatitis B nucleic acid vaccine, its preparation method and application
11/12/2008CN100431611C Compound of polypeptide-liposome and human vascular endothelial growth factor gene recombination plasmid and its use
11/11/2008US7449565 Chimeric tumor suppressor gene and protein
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449548 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
11/11/2008US7449545 Antimicrobial bolisin peptides
11/11/2008US7449492 Therapeutic agents—I
11/11/2008US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/11/2008US7449449 Providing microprojectiles carrying polynucleic acid sequences; accelerating the microprojectiles at the preselected-cells, with the microprojectiles contacting cells to penetrate vertebrate cells and deposit polynucleic acid
11/11/2008US7449333 Methods and compositions for tissue regeneration
11/11/2008US7449178 Attenuated gram negative bacteria
11/11/2008CA2588369A1 Methods of treatment and prevention of metabolic bone diseases and disorders
11/11/2008CA2588361A1 Methods of treatment and prevention of neurodegenerative diseases and disorders
11/09/2008CA2587185A1 Methods and compositions for the diagnosis and treatment of ewing's sarcoma
11/06/2008WO2008134767A2 Methods for treating and preventing multiple sclerosis
11/06/2008WO2008134720A2 Inert dna sequences for efficient viral packaging and methods of use
11/06/2008WO2008134406A1 Ischemia-induced neovascularization is enhanced by hcns-sc transplantation
11/06/2008WO2008134124A1 Ul97 inhibitors for treatment of proliferative disorders
11/06/2008WO2008134123A1 Ul97 for treatment of protein aggregate disorders
11/06/2008WO2008134069A2 Anchored ligand agents
11/06/2008WO2008133971A2 Promoter inducible by reactive oxygen species and vector comprising the same
11/06/2008WO2008133208A1 Method for enhancing immune response with peptide
11/06/2008WO2008133137A1 Vector for gene therapy
11/06/2008WO2008132729A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
11/06/2008WO2008132723A2 Therapeutic delivery of inhibitory nucleic acid molecules to the respiratory system
11/06/2008WO2008131807A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
11/06/2008WO2008131599A1 T-cell receptor vaccines materials and methods
11/06/2008WO2008112787A3 Method and apparatus of low strength electric field network-mediated delivery of therapeutics in solid organs
11/06/2008WO2008109779A3 Use of follistatin-like related gene (flrg) to increase muscle mass
11/06/2008WO2008107462A3 Plasmid containing a sequence encoding a disintegrin domain of metargidin (rdd)
11/06/2008WO2008100230A8 Membrane(s) and uses thereof
11/06/2008WO2008098208A3 Gnaq mutations in melanoma
11/06/2008WO2008077022A3 Himf and btk in pulmonary, cardiac, and inflammation disorders
11/06/2008WO2008061011A3 Intra-vascular kidney gene therapy with plasmid encoding bmp-7
11/06/2008WO2008057234A3 Modulation of t cell signaling threshold and t cell sensitivity to antigens
11/06/2008WO2008021196A3 Methods and compositions for the treatment of medical disorders
11/06/2008WO2007149433A3 Tumor-specific delivery of therapeutic agents via liposomase
11/06/2008WO2005028633A3 Modulation of rankl expression
11/06/2008US20080275218 Ly6h gene
11/06/2008US20080274995 Suppression of Nuclear Factor-KappaB Dependent Processes Using Oligonucleotides
11/06/2008US20080274990 Cog47 Protein and S100beta Gene Polymorphism
11/06/2008US20080274971 Use of ACRP30 Globular Head to Promote Increases in Muscle Mass and Muscle Differentiation
11/06/2008US20080274968 In vitro methods for detecting renal cancer
11/06/2008US20080274549 System and Method For Electroporating a Sample
11/06/2008US20080274472 Novel kinases and uses thereof
11/06/2008US20080274468 Novel means for the diagnosis and therapy of ctcl
11/06/2008US20080274139 Attenuated microorganisms for the treatment of infection
11/06/2008US20080274128 Heat shock protein-based vaccines and immunotherapies
11/06/2008US20080274112 Axonal growth receptor for use in designing immunoglobulins for prevention and treatment of nervous system, cardiovascular, vision and/or spinal cord injury
11/06/2008US20080274109 Nucleotide sequences coding chemokines for use in dianosis of infection, arteriosclerosis, autoimmune, inflammatory, allergic and arthritic disorders
11/06/2008US20080274084 Anti-Tnf Alpha Producing Lactic Acid Bacteria for the Treatment of Chronic Enterocolitis
11/06/2008US20080274077 Using Nogo receptor suppressant as therapeutic in treatment of nervous system and neurodegenerative disorders; axonal regeneration
11/06/2008US20080274045 Imaging, diagnosis and treatment of disease
11/06/2008CA2685394A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
11/06/2008CA2684724A1 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
11/06/2008CA2676808A1 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf)
11/05/2008EP1988163A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
11/05/2008EP1988102A1 Growth factor homolog ZVEGF3
11/05/2008EP1987845A2 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor.
11/05/2008EP1987148A1 De-differentiation of astrocytes into neural stem cell using bmi-1
11/05/2008EP1987143A1 De-differentiation of astrocytes into neural stem cell using nanog
11/05/2008EP1986696A2 Method for production of a transformed cell
11/05/2008EP1986667A1 Dendritic cells transiently transfected with a membrane homing polypeptide and their use
11/05/2008EP1986661A2 Gene therapy for niemann-pick disease type a
11/05/2008EP1986607A2 Method and process for preparing cardiolipin
11/05/2008EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof
11/05/2008EP1233782B1 Eliciting hcv-specific antibodies
11/05/2008CN101300346A Novel biological substance nesfatin and its related substances and uses thereof
11/05/2008CN101297967A Novel use of staphylococcus enterotoxin A gene
11/05/2008CN100430482C Novel expression vectors and uses thereof
11/05/2008CN100430478C CASB618 polynucleotides and polypeptides and their use
11/05/2008CN100430476C Tumor-lysing virus growing selectively in tumor cells
11/05/2008CN100430412C Nucleic acid molecule RTN4BSR6 and application for preparation of anti-cancer drugs
11/04/2008US7446191 Expression vector comprising nucleotide sequences coding t-cell receptor for use in generation of monoclonal antibody for treatement of cell proliferative disorders
11/04/2008US7446189 Use as vaccine adjuvants; useful in the treatment of autoimmune diseases and immunosuppression
11/04/2008US7446170 Polypeptide of given sequence; improved efficiency by using heparin binding domain derived from fibronectin; replication deficient vector
11/04/2008US7446168 Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) for use as a tool in treatment and prevention of urogenital and cell proliferative disorders; fertility aide
11/04/2008US7446099 Compositions and methods for biodegradable polymer-peptide mediated transfection
11/04/2008US7446098 combining gene therapy with active site-specific chaperones to increases the stability and efficiency of the protein encoded by the recombinant gene that is administered.
11/04/2008US7445930 Method for the production and purification of adenoviral vectors
11/04/2008US7445929 Recombinant adenovirus vector having a reduced side effect
11/04/2008US7445928 Bacterial artificial chromosome construct encoding recombinant coronavirus
11/04/2008US7445920 Member of the lysyl oxidase gene family
11/04/2008US7445793 Support for tissue regeneration and process for producing the same
11/04/2008CA2325360C Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
11/04/2008CA2182890C Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
10/2008
10/30/2008WO2008131431A2 Modulation of blood brain barrier protein expression
10/30/2008WO2008131191A2 Nucleic acids hybridizable to micro rna and precursors thereof
10/30/2008WO2008130100A1 Semi-mature dentritic cell
10/30/2008WO2008129971A1 Improved persistently infective sendai virus vector
10/30/2008WO2008129548A2 A system for delivering therapeutic agents into living cells and cells nuclei
10/30/2008WO2008129265A1 Diagnostics and therapeutics for diabetic nephropathy involving ccl18
10/30/2008WO2008128440A1 A series of recombinant adeno-associated viral vectors, construction methods and uses thereof
10/30/2008WO2008094687A3 Gep, a novel chondrogenic growth factor and target in cartilage disorders
10/30/2008WO2008093249A3 Obligate heterodimer meganucleases and uses thereof
10/30/2008WO2008089448A3 Methods and compositions for promoting survival & proliferation of endothelial cells & stimulating angiogenesis
10/30/2008WO2008086484A3 Compositions and methods for treating cardiovascular disease
10/30/2008WO2008075206A3 Cell-matrix microspheres, methods for preparation and applications
10/30/2008WO2008071093A8 Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10
1 ... 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 ... 870